1. A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults. Issue 12 (14th March 2016) Authors: Ostergaard, Lars; Lucksinger, Gregg H.; Absalon, Judith; Beeslaar, Johannes; Eiden, Joseph; Jansen, Kathrin U.; York, Laura J.; Quinn, Angela; Graversen, Mette E.; Perez, John L. Journal: Vaccine Issue: Volume 34:Issue 12(2016) Page Start: 1465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗